Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 15, 2024.
All times in Eastern Daylight Time.
-
TUC.technology in Paris - TUC.tiny and TUC.modular Dashboard World Premiere at Viva Technology 2024, May 22-25PARIS--(BUSINESS WIRE)--Just over a month after the Digital World Premiere, TUC.tiny is ready to make its debut at VivaTech 2024, the most important technology fair in Europe. In Hall 1, Pavilion 4... more »
-
Ubitus K.K. to Showcase at VivaTech 2024, Highlighting Innovations in AIGC and Cloud GamingPARIS--(BUSINESS WIRE)--Ubitus K.K. (hereinafter Ubitus), a leading cloud gaming technology provider, is thrilled to announce its participation in Viva Technology 2024, Europe’s biggest startup and... more »
-
FPT Software Renews HITRUST r2 Certification, Upholding The Highest Standards Of Security And ComplianceHANOI, Vietnam--(BUSINESS WIRE)--FPT Software, a leading global IT company, has earned HITRUST Risk-based, 2-year (r2) Certification for its Web Services System, Database System and Deployment Syst... more »
-
美格纳庆祝 “美格纳智芯科技” 在中国盛大开业韩国首尔--(BUSINESS WIRE)--(美国商业资讯)-- Magnachip Semiconductor Corporation(以下简称“美格纳”或“公司”)(NYSE:MX) 今天举行了庆祝仪式,庆祝总部位于中国合肥的美格纳智芯科技(合肥)有限公司 (“MTC”)盛大开业。MTC 是美格纳的一家子公司,为了拓展其在中国的显示驱动集成电路和电源集成电路业务,成立于 2023年 1... more »
-
ACTICOR BIOTECH: Presentation of the Main Results of the Phase 2/3 ACTISAVE Study in the Treatment of Stroke at ESOC 2024PARIS--(BUSINESS WIRE)--Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the tr... more »
-
ACTICOR BIOTECH : Présentation des principaux résultats de l’étude de phase 2/3 ACTISAVE dans le traitement de l’AVC lors de l’ESOC 2024PARIS--(BUSINESS WIRE)--Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 – ALACT) (Paris:ALACT), entreprise biopharmaceutique au stade clinique qui développe glenzocimab, un médicament innovant pour ... more »
-
TOKYO--(BUSINESS WIRE)-- MUFG Bank, Ltd. announces Consolidated Summary Report <under Japanese GAAP> for the fiscal year ended March 31, 2024 May 15, 2024 Company name: Mitsubishi UFJ Financ... more »
-
Interactive Brokers Launches Cryptocurrency Trading for UK ClientsGREENWICH, Conn.--(BUSINESS WIRE)--Interactive Brokers (Nasdaq: IBKR) today announced the launch of cryptocurrency trading in the United Kingdom as a new addition to its platform. more »
-
Esperanto Technologies and Rapidus Partner to Enable More Energy-Efficient Designs for the Coming “Post GPU Era”MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Esperanto Technologies™, the leading developer of high-performance, energy-efficient artificial intelligence (AI) and high-performance computing (HPC) soluti... more »
-
PurpleCube AI partners with Snowflake to Revolutionize Data Engineering with Next-Generation AI and Machine LearningSAN FRANCISCO--(BUSINESS WIRE)--PurpleCube AI, a unified data orchestration platform, has partnered with Snowflake, the Data Cloud company, to drive data-driven innovation at unprecedented speed an... more »
-
Enhanc3D Genomics Appoints Hazel Jones as Chief Executive OfficerCAMBRIDGE, England--(BUSINESS WIRE)--Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification... more »
-
Gradiant Launches ForeverGone, the Industry’s Only Complete PFAS Removal and Destruction SolutionBOSTON--(BUSINESS WIRE)--Today Gradiant launched ForeverGoneTM, the industry’s only complete all-in-one solution to permanently remove and destroy PFAS. more »
-
Rapid Medical™ führt mit weltweit erstem Thrombektomie-Roboter erfolgreiche Eingriffe bei ischämischem Schlaganfall durchYOKNEAM, Israel, und DALLAS--(BUSINESS WIRE)--Rapid Medical™, ein führender Entwickler fortschrittlicher neurovaskulärer Produkte, meldet die erste erfolgreiche robotische Thrombektomie, die in Med... more »
-
Rapid Medical™ réalise avec succès des procédures d’AVC ischémique avec le premier dispositif robotique de thrombectomie au mondeYOQNEAM, Israël et DALLAS--(BUSINESS WIRE)--Rapid Medical™, l'un des principaux développeurs de dispositifs neurovasculaires avancés, annonce la première thrombectomie robotisée réussie à Medellín,... more »
-
Riassunto: Rapid Medical™ completa varie procedure con esito positivo riguardanti l’ictus ischemico mediante il primo dispositivo robotico al mondo per trombectomiaYOKNEAM, Israele e DALLAS--(BUSINESS WIRE)--Rapid Medical™, una delle principali società nello sviluppo di dispositivi neurovascolari avanzati, annuncia l’esecuzione con esito positivo della prima ... more »